Effect of Intraperitoneal Administration of Low-Molecular-Weight Heparin on Plasma Tissue Factor Pathway Inhibitor Levels in CAPD Patients

Publisher： Karger

E-ISSN： 2235-3186|91|1|162-163

ISSN： 1660-8151

Source： Nephron, Vol.91, Iss.1, 2002-05, pp. : 162-163

Disclaimer: Any content in publications that violate the sovereignty, the constitution or regulations of the PRC is not accepted or approved by CNPIEC.

Previous Menu Next

Abstract

Related content

Standard Heparin versus Low-Molecular-Weight Heparin

By  

Nephron, Vol. 92, Iss. 3, 2002-09 ,pp. : 589-600

Karger

Access to resources Recommend Favorite

Intraperitoneal Application of Low-Molecular-Weight Heparin in Continuous Ambulatory Peritoneal Dialysis in a Child

By  

Nephron, Vol. 86, Iss. 4, 2000-12 ,pp. : 545-545

Karger

Access to resources Recommend Favorite

Long-Term Use of Low-Molecular-Weight Heparin in Hemodialysis Patients: A 7-Year Experience

By  

Blood Purification, Vol. 27, Iss. 3, 2009-02 ,pp. : 242-245

Karger

Access to resources Recommend Favorite

Low Molecular Weight Heparin Reduces Triglyceride, VLDL and Cholesterol/HDL Levels in Hyperlipidemic Diabetic Patients on Hemodialysis

By  

American Journal of Nephrology, Vol. 18, Iss. 5, 1998-09 ,pp. : 384-390

Karger

Access to resources Recommend Favorite

Anaphylactoid Reaction Induced by Low-Molecular-Weight Heparin in a Hemodialysis Patient

By  

Nephron, Vol. 87, Iss. 1, 2001-01 ,pp. : 93-94

Karger

Access to resources Recommend Favorite